After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Assess tax efficiency between retirement strategies focusing on Total World exposure to boost after-tax returns.
28,221 articlesA biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Rocket Lab posted solid Q4 FY2025 revenue above estimates, while warning that the Neutron program faces a timeline sh...
A recent enforcement operation in Maine ended with a fatal shooting after a vehicle attempted to flee. The incident r...
South Korea's National Tax Service publicly released seed phrases tied to seized crypto, enabling thieves to drain ro...
Lamborghini posted a record year for deliveries in 2025, but import tariffs trimmed profits and narrowed margins. The...
Tesla unveils Terafab, a new in-house semiconductor fabrication unit focused on robotics and AI chips. Early signals ...
When a company's top medical officer sells a large block and leaves with a zero direct stake, investors notice. This ...
A rapid Trump-backed rally has pushed stocks to fresh highs, yet selective bargains remain. The market shows pockets ...
SCHD has surged in 2026, outpacing the S&P 500 as dividend-growth funds draw cash-flow hungry investors. Three core E...
Actor Niko Foster has placed a 14,000-square-foot Nevada mansion on the market for $22 million, spotlighting Strip vi...
Jim Cramer addressed a caller whose portfolio was heavily concentrated in NVIDIA, using the moment to discuss whether...
Markets remain choppy as 2026 unfolds. This article lays out practical steps to shield portfolios and stay resilient ...